RBC Capital raised the firm’s price target on SS&C to $96 from $86 and keeps an Outperform rating on the shares after its Q4 earnings beat. In line with the trend over the past several quarters, organic growth accelerated and appears to be attaining more sustainable levels than in years past, as the company’s investment cadence on new products and services, pricing discipline, and overall health of its clients are all supportive of mid-point organic growth of 5% in FY25, the analyst tells investors in a research note.